IQVIA SOLUTIONS B.V.
Desconocido
SPIDeRR: Stratification of Patients using advanced Integrative modeling of Data Routinely acquired for diagno...
Globally 1.Globally 1.71 billion people have musculoskeletal symptoms, the leading contributor to disability. Early disease stratification i...
2023-03-20 - 2028-04-30 | Financiado
2023-03-20 - 2028-04-30 | Financiado
More-EUROPA: More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making
IQVIA SOLUTIONS B.V.
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2022-TOOL-11
While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world...
2022-11-24 - 2027-12-31 | Financiado
2022-11-24 - 2027-12-31 | Financiado
* No se disponen de datos de la empresa actual.